Substrain-specific differences in bone parameters, alpha-2-macroglobulin circulating levels, and osteonecrosis incidence in a rat model
Open Access
- 19 February 2016
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 35 (6) , 1183-1194
Abstract
Osteonecrosis of the femoral head (ONFH) is a potentially devastating complication that occurs in up to 40% of young adults receiving chronic glucocorticoid (GC) therapy. Through a validated GC therapy rat model, we have previously shown that Wistar Kyoto (WK) rats exhibit a genetic susceptibility to GC-induced ONFH compared to Sasco Fischer (F344) rats. We have undertaken this study in order to investigate differences between these two strains for their bone parameters, alpha-2-macroglobulin (A2M) circulating levels and incidence of GC-induced osteonecrosis of the femoral head. WK and F344 rats were treated either with 1.5 mg/kg/day of prednisone or placebo for 6 months. Blood was taken every month. The femoral heads were harvested for histological examination to detect ONFH and analyzed with micro-computed tomography. After 3 months of GC-therapy, plasma A2M was elevated in treated rats only. GC-treated WK rats exhibited histological evidence of early ONFH through higher rates of cellular apoptosis and empty osteocyte lacunae in the subchondral bone compared to placebos and to F344 rats. Furthermore, micro-CT analysis exhibited femoral head collapse only in GC-treated WK rats. Interestingly, GC-treated F344 rats exhibited significant micro-CT changes, but such changes were less concentrated in the articular region and were accompanied histologically with increased marrow fat. These µCT and histological findings suggest that elevated A2M serum level is not predictive and suitable as an indicative biomarker for early GC-induced ONFH in rodents. Elevated A2M levels observed during GC treatment suggests that it plays role in the host reparative response to GC-associated effects. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:1183–1194, 2017.Keywords
Funding Information
- Leukemia and Lymphoma Society
- Santé
- Yvon Boulanger Foundation
- Canadian Institutes of Health Research
- FRQS-sponsored Réseau de recherche en santé buccodentaire et osseuse (RSBO)
- McGill University
- NCE-MITACS Accelerate
- RI-MUHC (CG)
This publication has 38 references indexed in Scilit:
- Receptor-Recognized α2-Macroglobulin Binds to Cell Surface-Associated GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer CellsPLOS ONE, 2012
- The Pathogenesis of Nontraumatic OsteonecrosisArthritis, 2012
- Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic ProteasomeInternational Journal of Proteomics, 2012
- A rat model of early stage osteonecrosis induced by glucocorticoidsJournal of Orthopaedic Surgery and Research, 2011
- Interactome mapping suggests new mechanistic details underlying Alzheimer's diseaseGenome Research, 2010
- New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat modelArthritis Research & Therapy, 2010
- Apoptosis in the Osteonecrosis of the Femoral HeadClinics in Orthopedic Surgery, 2010
- Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral headActa Orthopaedica, 2009
- Binding of α2ML1 to the Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) Reveals a New Role for LRP1 in the Human EpidermisPLOS ONE, 2008
- Cardiac isoform of alpha-2 macroglobulin—A new biomarker for myocardial infarcted diabetic patientsAtherosclerosis, 2006